1-20 of 22
Shangbin Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impaired Cognitive Function in Immune-TTP Is Better Predicted By Serum Thrombomodulin Than ADAMTS13 Activity: Results of a Longitudinal Multicenter Pilot Study

Aaron Boothby, Michael D Evans, Shangbin Yang, Senthil Sukumar, James G Scott, Deirdra Terrell, Spero Cataland, Marshall Mazepa
Journal: Blood
Blood (2023) 142 (Supplement 1): 1258.
https://doi.org/10.1182/blood-2023-181094
Published: 2023
Journal Articles

Relapse Prediction Model for Immune-Mediated Thrombotic Thrombocytopenic Purpura

Camila Masias, MDMPH, Shangbin Yang, PhD, Senthil Sukumar, MD, Alcinda Flowers, MD, Haiwa Wu, Krista Carter, Shili Lin, Chenggon Han, Spero Cataland
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-142117
Published: 2020
Journal Articles

A Pilot Study on Biomarkers of Vascular Injury in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Camila Masias, MDMPH, Rawan Tarawneh, MD, Haiwa Wu, Krista Carter, Shangbin Yang, PhD, Alcinda Flowers, MD, Marie Scully, Spero Cataland, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2377.
https://doi.org/10.1182/blood-2019-130369
Published: 2019
Journal Articles

Severely Deficient ADAMTS13 Activity Predicts Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Pregnancy

Camila Masias, MDMPH, Krista Carter, Haiwa Wu, Shangbin Yang, PhD, Alcinda Flowers, MD, Spero Cataland, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1098.
https://doi.org/10.1182/blood-2019-130561
Published: 2019
Journal Articles

Prediction of Relapse Based on Remission ADAMTS13 Activity in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Camila Masias Castanon, MD, Clare Stevens, BS/CCRP, Lauren Jay, Haiwa Wu, Michael McGookey, Jian Chen, MD, James N. George, MD, Shangbin Yang, PhD, Spero R Cataland, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4843.
https://doi.org/10.1182/blood.V130.Suppl_1.4843.4843
Published: 2017
Journal Articles

A Prospective, Randomized Study of Cyclosporine or Corticosteroids As an Adjunct to Plasma Exchange for the Treatment of Thrombotic Thrombocytopenic Purpura

Spero Cataland, Shangbin Yang, PhD, Camila Masias Castanon, MD, Michael McGookey, Haiwa Wu, Susan Geyer, PhD, James N. George, MD, Lauren Jay, Haifeng M Wu, MD
Journal: Blood
Blood (2016) 128 (22): 133.
https://doi.org/10.1182/blood.V128.22.133.133
Published: 2016
Journal Articles

No Major Differences in Outcomes Between the Initial and Relapse Episodes in Patients with Thrombotic Thrombocytopenic Purpura: The Experience from the Ohio State University Registry

Camila Masias Castanon, MD, Haiwa Wu, Michael McGookey, Lauren Jay, Haifeng Wu, MD, Spero R Cataland, MD, Shangbin Yang, PhD
Journal: Blood
Blood (2016) 128 (22): 2544.
https://doi.org/10.1182/blood.V128.22.2544.2544
Published: 2016
Journal Articles

Time-Dependent Activation of Complement system during Storage of Platelet Product

Jian Chen, MD PhD, Shangbin Yang, PhD, Spero R Cataland, MD, Haifeng M Wu, MD
Journal: Blood
Blood (2014) 124 (21): 4287.
https://doi.org/10.1182/blood.V124.21.4287.4287
Published: 2014
Journal Articles

Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP

Clinical Trials & Observations
Spero R. Cataland, V. Michael Holers, Susan Geyer, Shangbin Yang, Haifeng M. Wu
Journal: Blood
Blood (2014) 123 (24): 3733–3738.
https://doi.org/10.1182/blood-2013-12-547067
Published: 2014
Includes: Supplemental data
Journal Articles

Alternative and Terminal Complement Pathway Biomarkers At Presentation More Precisely Define The Clinical Diagnosis Of aHUS

Spero R Cataland, M.D., V. Michael Holers, M.D., Shangbin Yang, Ph.D., Haifeng M Wu, M.D.
Journal: Blood
Blood (2013) 122 (21): 3552.
https://doi.org/10.1182/blood.V122.21.3552.3552
Published: 2013
Journal Articles

Diagnostic and Prognostic Values Of ADAMTS13 Activity Measured During Daily Plasma Exchange Therapy In Patients With Acquired TTP

Nan Wu, Shangbin Yang, Ph.D., Spero R Cataland, M.D., Haifeng M Wu, M.D.
Journal: Blood
Blood (2013) 122 (21): 1079.
https://doi.org/10.1182/blood.V122.21.1079.1079
Published: 2013
Journal Articles

Complement Activation in Patients with Acquired Thrombotic Thrombocytopenic Pupura (TTP)

Shangbin Yang, Spero R Cataland, M.D., V. Michael Holers, M.D., Ante S Lundberg, M.D., Haifeng Wu, M.D.
Journal: Blood
Blood (2012) 120 (21): 3323.
https://doi.org/10.1182/blood.V120.21.3323.3323
Published: 2012
Journal Articles

Mortality From Thrombotic Thrombocytopenic Purpura Is Related to Complement Hyperactivation

Trudy C. Wu, Shangbin Yang, Sara Haven, V. Michael Holers, M.D., Ante S. Lundberg, M.D., Haifeng Wu, M.D., Spero R. Cataland, M.D.
Journal: Blood
Blood (2012) 120 (21): 488.
https://doi.org/10.1182/blood.V120.21.488.488
Published: 2012
Journal Articles

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

Luca A. Lotta, Haifeng M. Wu, Ian J. Mackie, Marina Noris, Agnes Veyradier, Marie A. Scully, Giuseppe Remuzzi, Paul Coppo, Ri Liesner, Roberta Donadelli, Chantal Loirat, Richard A. Gibbs, April Horne, Shangbin Yang, Isabella Garagiola, Khaled M. Musallam, Flora Peyvandi
Journal: Blood
Blood (2012) 120 (2): 440–448.
https://doi.org/10.1182/blood-2012-01-403113
Published: 2012
Includes: Supplemental data
Journal Articles

Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype

Luca A Lotta, Haifeng M Wu, Marie A Scully, Marina Noris, Agnes Veyradier, Ian J Mackie, PhD FRCPath, Giuseppe Remuzzi, Paul Coppo, Ri Liesner, Roberta Donadelli, Chantal Loirat, MD, Richard A Gibbs, April Horne, Shangbin Yang, Roberta Palla, Flora Peyvandi
Journal: Blood
Blood (2011) 118 (21): 2219.
https://doi.org/10.1182/blood.V118.21.2219.2219
Published: 2011
Journal Articles

Title: Pretreatment ADAMTS13 Activity Predicts Clinical Outcome in Patients with Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Spero R Cataland, M.D., Susan Geyer, PhD, Shangbin Yang, Haifeng Wu, M.D.
Journal: Blood
Blood (2011) 118 (21): 2224.
https://doi.org/10.1182/blood.V118.21.2224.2224
Published: 2011
Journal Articles

A Randomized, Double-Blind, Placebo-Controlled, Clinical Outcome Study of ARC1779 In Patients with Thrombotic Thrombocytopenic Purpura (TTP)

Spero R Cataland, MD, Flora Peyvandi, MD, PhD, Pier M. Mannucci, MD, Bernhard Lämmle, Johanna A Kremer Hovinga, MD, Samuel J Machin, Marie Scully, Gail Rock, PhD, MD, FRCP, James Gilbert, MD, Paul Knoebl, Shangbin Yang, PhD, Haifeng Wu, M.D., Bernd Jilma, MD
Journal: Blood
Blood (2010) 116 (21): 726.
https://doi.org/10.1182/blood.V116.21.726.726
Published: 2010
Journal Articles

Comparison of Clinical Outcomes Between Initial and Relapsed Events of Thrombotic Thrombocytopenic Purpura In a Large TTP Cohort.

Haifeng Wu, M.D., Elizabeth Biller, M.D., Shangbin Yang, Ph.D., Eric H. Kraut, MD, Spero Cataland, M.D., Susan Geyer, PhD
Journal: Blood
Blood (2010) 116 (21): 1439.
https://doi.org/10.1182/blood.V116.21.1439.1439
Published: 2010
Journal Articles

Longitudinal Analysis of VWF Multimerization Patterns In a well-defined TTP Cohort

Shangbin Yang, PhD, Sara Haven, Ming Jin, M.D., Susan Geyer, PhD, Spero R Cataland, M.D., Haifeng Wu, M.D.
Journal: Blood
Blood (2010) 116 (21): 4308.
https://doi.org/10.1182/blood.V116.21.4308.4308
Published: 2010
Journal Articles

Rapid Genotyping of SNPs Influencing Warfarin Drug Response by SELDI-TOF Mass Spectrometry

Shangbin Yang, Lihui Xu, Haifeng Wu
Journal: Blood
Blood (2008) 112 (11): 4053.
https://doi.org/10.1182/blood.V112.11.4053.4053
Published: 2008